ArticleCureus2024

The Potential Adverse Impact of Post-Treatment Thrombocytopenia on Clinical Outcomes in Cancer Patients Treated With Immune Checkpoint Inhibitors.

Asım Armağan Aydın et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.